Cargando…
Therapeutic angiogenesis for cardiovascular disease
The identification of angiogenic growth factors, such as vascular endothelial growth factor and fibroblast growth factor, has fueled interest in using such factors to induce therapeutic angiogenesis. The results of numerous animal studies and clinical trials have offered promise for new treatment st...
Autores principales: | Ng, Yin-Shan, D'Amore, Patricia A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC64829/ https://www.ncbi.nlm.nih.gov/pubmed/11806814 http://dx.doi.org/10.1186/cvm-2-6-278 |
Ejemplares similares
-
Update on the Role of the Endothelial Glycocalyx in Angiogenesis and Vascular Inflammation
por: Hu, Zhengping, et al.
Publicado: (2021) -
Therapeutic angiogenesis in cardiovascular disease
por: Al Sabti, Hilal
Publicado: (2007) -
Therapeutic Angiogenesis for Treating Cardiovascular Diseases
por: Deveza, Lorenzo, et al.
Publicado: (2012) -
Protein kinase CK2: a potential therapeutic target for diverse human diseases
por: Borgo, Christian, et al.
Publicado: (2021) -
Immune and Inflammatory Cells of the Tumor Microenvironment Represent Novel Therapeutic Targets in Classical Hodgkin Lymphoma
por: Calabretta, Eleonora, et al.
Publicado: (2019)